Log In
Print
BCIQ
Print
Print this Print this
 

Bonalon, Fosamax, alendronate

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionOral formulation of alendronate sodium hydrate
Molecular Target Not available
Mechanism of ActionInhibits bone resorption
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today